Flibanserin is a new drug currently under inspection developed for the prevention of woman HSDD – Hypoactive Sexual Desire Disorder. HSDD is a fairly new medical name for physically healthy woman experiencing low libido or a highly decreased sexual desire. According to some conducted studies, 10%-20% of women are experiencing such problems and some even claim HSDD outnumbers men with some kind of sexual problems. Flibanserin is a 5-HT serotonin receptor agonist and dopamine D4 receptor partial agonist, a Non-Hormonal agent that basically increases the level of dopamine and noradrenalin and in the same lowers the serotonin level in the brain. This process apparently positively influences the sexual desire of women with otherwise low libido. The main advantage of this Non-Hormonal drug lies in fact that is has no side effects commonly associated with various hormonal treatments such as negatively altered mood.

Flibanserin, or on its believed trademark name Girosa, produced by a German pharmaceutical company, Boehringer Ingelheim GmbH, was initially developed as an anti-depressant, but after some tests it turned out to be a deficient depression treatment. In the same way Viagra® was also originally developed as a treatment for high blood pressure and angina (a type of heart condition). While females were asked about their experimental experiences for depression, a high number of them remarked a surprising positive side effect from the use of Flibanserin. Most women reported an increased sexual interest and more general satisfying sexual experience than before. Apparently some women involved in the trials did not want to stop the experiment based just on this fact, which resulted in the company to clinically test this new agent for precisely this reason. Is it possible for this drug to really amplify the sexual desire of women?

The reported side effects of the drug were generally low to modest, including some level of anxiety, dizziness, insomnia, fatigue, dry mouth or nausea. Not all individuals involved in the study reported having all these side effects but there were more times reported as the placebo group. As this is a rather new compound there are no long term studies regarding these possible side effects.